Earum Pharmaceuticals Ltd. - Research Center
750783 EARUM-RE Group (R) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Profit before tax | 3.08 | 0.12 | 2.45 | 2.28 | 1.24 |
| Net cashflow-operating activity | 2.61 | -5.80 | -3.45 | -0.48 | -3.54 |
| Net cash used in investing activity | 0.06 | 2.94 | -3.45 | -0.32 | -0.05 |
| Netcash used in fin. activity | -2.59 | 2.90 | 6.76 | 0.94 | 3.43 |
| Net inc/dec in cash and equivlnt | 0.08 | 0.03 | -0.14 | 0.14 | -0.16 |
| Cash and equivalnt begin of year | -1.24 | 0.03 | 0.16 | 0.02 | 0.18 |
| Cash and equivalnt end of year | -1.15 | 0.06 | 0.03 | 0.16 | 0.02 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis